<DOC>
	<DOCNO>NCT01554579</DOCNO>
	<brief_summary>The purpose study assess efficacy single dose level AF-219 subject moderate severe pain associate osteoarthritis ( OA ) knee compare placebo 4 week treatment . The study also assess safety tolerability , change physical function , stiffness , treatment response health outcome .</brief_summary>
	<brief_title>A Four-Week Multicenter Study Evaluating Safety Efficacy AF-219 Subjects With Osteoarthritis Knee</brief_title>
	<detailed_description>Subjects satisfy entry criterion Screening enter Washout Phase , discontinue current nonsteroidal anti-inflammatory drug ( NSAID ) therapy . Up 220 subject fulfill flare ( entry ) criterion randomize AF-219 placebo . Subjects complete Treatment Visits 1 , 2 , 3 , 4 week start study drug . At Treatment Visit , subject undergo efficacy assessment safety procedure . During Washout Treatment Phases subject complete 'average pain ' Numeric Pain Rating Scale ( NPRS ) count rescue medication use precede 24 hour . Subjects return 2 week last Treatment Visit ( Follow-Up Visit ) .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Men woman Women child bear potential must pregnant study must use two form birth control Men female partner must use two form birth control Clinical radiographic evidence chronic knee osteoarthritis An average NPRS score &gt; =5 &lt; =9 47 day washout period previous osteoarthritis medication Ambulatory Have provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>